IL2 and neoplasm: Higher tumor aggressiveness was also shown by the upregulation of the anti-inflammatory markers, IL-6 and IL-10, the upregulation of the proinflammatory marker Il-2, and the downregulation of TP53 and TIMP-1 [59].